| 1 | 1H/31P magnetic resonance spectroscopy | - | - | - | - | [1] 77 77 💬
|
| 2 | 76517-01-4 | - | - | - | - | [1] 77 77 💬
|
| 3 | 81409-90-7 | - | - | - | - | [1] 77 77 💬
|
| 4 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [14] 11 11, 19, 34, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
|
| 5 | Acetato DE octreótida | - | - | - | - | [1] 77 77 💬
|
| 6 | Adipose tissue biopsy | - | - | - | - | [1] 77 77 💬
|
| 7 | Alesse | - | - | - | - | [1] 77 77 💬
|
| 8 | ATL1103 | - | - | - | - | [1] 77 77 💬
|
| 9 | Avandia*28CPR RIV 4MG | [1] Rosiglitazone Rosiglitazone | [2] Rosiglitazone maleate
Rosiglitazone maleate
,
Rosiglitazone
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 77 77 💬
|
| 10 | BIM 23a760 | - | - | - | - | [1] 77 77 💬
|
| 11 | BIM23a760 | - | - | - | - | [1] 77 77 💬
|
| 12 | BIM23b065 | - | - | - | - | [1] 77 77 💬
|
| 13 | Blood tests: IGF-1, AST/ALT/ALP/tbil, GTT | - | - | - | - | [1] 77 77 💬
|
| 14 | C2L-OCT-01 PR | - | - | - | - | [1] 77 77 💬
|
| 15 | C2L-OCT-01 PR , 10MG | - | - | - | - | [1] 77 77 💬
|
| 16 | C2L-OCT-01 PR , 20MG | - | - | - | - | [1] 77 77 💬
|
| 17 | C2L-OCT-01 PR , 30MG | - | - | - | - | [1] 77 77 💬
|
| 18 | C2L-OCT-01 PR 30 MG | - | - | - | - | [1] 77 77 💬
|
| 19 | C2L-OCT-01 PR, 10 or 20 MG | - | - | - | - | [1] 77 77 💬
|
| 20 | C2L-OCT-01 PR, 20 MG | - | - | - | - | [1] 77 77 💬
|
| 21 | C2L-OCT-01 PR, 30 MG | - | - | - | - | [1] 77 77 💬
|
| 22 | Cabaser | - | - | - | - | [2] 6 6, 77 💬
|
| 23 | Cabergolin | - | - | - | - | [1] 77 77 💬
|
| 24 | Cabergoline | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [4] 6 6, 74, 75, 77 💬
|
| 25 | CAM2029 | - | - | - | - | [1] 77 77 💬
|
| 26 | CAM2029 (octreotide subcutaneous depot) _prefilled syringe_prefilled syringe | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 27 | CAM2029 (octreotide subcutaneous depot)_ prefilled PEN | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 28 | CAM2029 (octreotide subcutaneous depot)_ prefilled syringe | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 29 | CAM2029 (octreotide subcutaneous depot)_pre-filled PEN | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 30 | CAM2029 (octreotide subcutaneous depot)_pre-filled syringe | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 31 | CAM2029 (octreotide subcutaneous depot)_prefilled PEN | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 32 | CAM2029 (octreotide subcutaneous depot)_prefilled syringe | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 33 | CAM2029-BR | - | - | - | - | [1] 77 77 💬
|
| 34 | Cialis - 20 MG 2 compresse rivestite CON film IN blister USO orale | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬
| [1] PDE5 PDE5 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 75 75, 77 💬
|
| 35 | Clomiphene citrate | [1] Clomifene Clomifene | [2] Clomiphene citrate
Clomiphene citrate
,
Clomifene
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [2] 74 74, 77 💬
|
| 36 | Cmri | - | - | - | - | [3] 51 51, 77, 86 💬
|
| 37 | Combination with dopamine agonist cabergoline | - | - | - | - | [1] 77 77 💬
|
| 38 | Combination with somatostatin analogue octreotide | - | - | - | - | [1] 77 77 💬
|
| 39 | CRN00808 | - | - | - | - | [1] 77 77 💬
|
| 40 | CRN00808 IS AN oral NON-peptide small molecule somatostatin receptor 2 (SST2) agonist | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 41 | CRN00808 è UN agonista DEL recettore 2 della somatostatina (SST2), orale, NON peptidico A piccole dimensioni molecolari | - | - | - | - | [1] 77 77 💬
|
| 42 | CRN00808.HCL | - | - | - | - | [1] 77 77 💬
|
| 43 | Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D) TRP-LY pamoate | - | - | - | - | [1] 77 77 💬
|
| 44 | Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LY pamoate | - | - | - | - | [1] 77 77 💬
|
| 45 | Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS pamoate | - | - | - | - | [1] 77 77 💬
|
| 46 | Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS-TYR(BZL)-PHE) pamoate | - | - | - | - | [1] 77 77 💬
|
| 47 | D-phenylalanyl-L-H | - | - | - | - | [1] 77 77 💬
|
| 48 | D-phenylalanyl-L-HE | - | - | - | - | [1] 77 77 💬
|
| 49 | D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-trypto | - | - | - | - | [1] 77 77 💬
|
| 50 | D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophan | - | - | - | - | [1] 77 77 💬
|
| 51 | D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemiscystyl-L-threonino | - | - | - | - | [1] 77 77 💬
|
| 52 | Debio 4126 | - | - | - | - | [1] 77 77 💬
|
| 53 | Denosumab | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [10] 46 46, 50, 70, 75, 77, 93, 95, 96, 274, 299 💬
|
| 54 | DG3173 | - | - | - | - | [1] 77 77 💬
|
| 55 | Direct surgery FOR acromegaly | - | - | - | - | [1] 77 77 💬
|
| 56 | Dopamine | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [3] 6 6, 7, 77 💬
|
| 57 | Dopastatin | [1] Dopastatin Dopastatin | - | - | - | [1] 77 77 💬
|
| 58 | Dostinex | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 59 | Dostinex 0,5 MG tabletten | - | - | - | - | [1] 77 77 💬
|
| 60 | Dostinex 0.5MG tabletts | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 61 | Dostinex 2CPR 0,5MG | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 62 | Empagliflozin | [1] Empagliflozin Empagliflozin | [1] Empagliflozin
Empagliflozin
💬
| - | - | [10] 65 65, 67, 72, 77, 86, 96, 97, 257, 298, 299 💬
|
| 63 | Escitalopram 10 MG | [1] Escitalopram Escitalopram | [2] Escitalopram oxalate
Escitalopram oxalate
,
Escitalopram
💬
| [1] SLC6A4 SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 77 77 💬
|
| 64 | Escitalopram hexal 10 MG | [1] Escitalopram Escitalopram | [2] Escitalopram oxalate
Escitalopram oxalate
,
Escitalopram
💬
| [1] SLC6A4 SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 77 77 💬
|
| 65 | Evista 60MG FILM-coated tablets | [1] Raloxifene Raloxifene | [2] Raloxifene hydrochloride
Raloxifene hydrochloride
,
Raloxifene
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 77 77 💬
|
| 66 | Furosemide | [1] Furosemide Furosemide | [1] Furosemide
Furosemide
💬
| [1] SLC12A2 SLC12A2 💬
| [3] Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | [2] 77 77, 86 💬
|
| 67 | Gadolinium | [1] Gadolinium Gadolinium | - | - | - | [4] 46 46, 77, 86, 305 💬
|
| 68 | Gamma knife radiosurgery | - | - | - | - | [1] 77 77 💬
|
| 69 | Genotropin | [1] Somatotropin Somatotropin | [1] Somatropin
Somatropin
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [5] 13 13, 77, 107, 187, 193 💬
|
| 70 | GHR-LRX | - | - | - | - | [1] 77 77 💬
|
| 71 | Glucose | [1] Dextrose, unspecified form Dextrose, unspecified form | [2] Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | [9] 6 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
|
| 72 | Growth hormone | [1] Somatotropin Somatotropin | [1] Somatropin
Somatropin
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [16] 2 2, 19, 46, 77, 78, 96, 97, 107, 113, 156, 191, 193, 195, 238, 265, 299 💬
|
| 73 | Growth hormone receptor antagonist | [1] Somatotropin Somatotropin | [1] Somatropin
Somatropin
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 74 | H01C B03 | - | - | - | - | [1] 77 77 💬
|
| 75 | Home administration | - | - | - | - | [1] 77 77 💬
|
| 76 | Implante DE octreótida | - | - | - | - | [1] 77 77 💬
|
| 77 | Insulin | - | - | - | - | [6] 6 6, 13, 46, 75, 77, 299 💬
|
| 78 | Ionis GHR-LRX | - | - | - | - | [1] 77 77 💬
|
| 79 | Ionis-GHR-LRX | - | - | - | - | [1] 77 77 💬
|
| 80 | Ipstyl | - | - | - | - | [1] 77 77 💬
|
| 81 | Ipstyl - 60 MG soluzione iniettabile PER USO sottocutaneo 1 siringa preriempita | - | - | - | - | [1] 77 77 💬
|
| 82 | Ipstyl - 90 MG soluzione iniettabile PER USO sottocutaneo 1 siringa preriempita | - | - | - | - | [1] 77 77 💬
|
| 83 | Ipstyl 120 MG | - | - | - | - | [1] 77 77 💬
|
| 84 | Ipstyl 90 MG | - | - | - | - | [1] 77 77 💬
|
| 85 | Ipstyl autogel | - | - | - | - | [1] 77 77 💬
|
| 86 | Isis 766720 | - | - | - | - | [1] 77 77 💬
|
| 87 | IT IS A chimera OF A dopamin 2 and AN somatostatin 2 receptor agonist | - | - | - | - | [1] 77 77 💬
|
| 88 | ITF2984 1000 MCG | - | - | - | - | [1] 77 77 💬
|
| 89 | ITF2984 2000 MCG | - | - | - | - | [1] 77 77 💬
|
| 90 | ITF2984 500 MCG | - | - | - | - | [1] 77 77 💬
|
| 91 | ITF2984 diacetate | - | - | - | - | [1] 77 77 💬
|
| 92 | Ketogenic diet | - | - | - | - | [9] 13 13, 19, 21, 49, 67, 77, 127, 145, 148 💬
|
| 93 | Lanreotida autogel 120 MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 94 | Lanreotide | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 67 67, 73, 77 💬
|
| 95 | Lanreotide (autogel formulation), duration OF treatment 24-56 weeks, depending ON dose interval | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 96 | Lanreotide (autogel formulation), duration OF treatment 46-48 weeks | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 97 | Lanreotide 60MG solution FOR injection | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 98 | Lanreotide acetate | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [4] 67 67, 77, 85, 298 💬
|
| 99 | Lanreotide acetato | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 100 | Lanreotide ATG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 101 | Lanreotide ATG 120MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 102 | Lanreotide autogel | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 103 | Lanreotide autogel 120 MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 104 | Lanreotide autogel 120MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 105 | Lanreotide autogel and octreotide LAR | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 106 | Lanreotide PRF | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 107 | Lanreotide-autogel 120 MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 108 | Liraglutide | [1] Liraglutide Liraglutide | [1] Liraglutide
Liraglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5] 6 6, 13, 75, 77, 193 💬
|
| 109 | Medical history, demographics | - | - | - | - | [1] 77 77 💬
|
| 110 | Medications FOR acromegaly | - | - | - | - | [1] 77 77 💬
|
| 111 | Mediterranean diet | - | - | - | - | [6] 13 13, 77, 96, 97, 265, 299 💬
|
| 112 | Metformin | [1] Metformin Metformin | [2] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| [2] PRKAA PRKAA, PRKAA 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [23] 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
|
| 113 | Mycapssa | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 114 | Octreolin | - | - | - | - | [1] 77 77 💬
|
| 115 | Octreotid | - | - | - | - | [1] 77 77 💬
|
| 116 | Octreotida | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 117 | Octreotida acetato | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 118 | Octreotidacetat | - | - | - | - | [1] 77 77 💬
|
| 119 | Octreotide | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [8] 67 67, 75, 77, 84, 85, 89, 193, 227 💬
|
| 120 | Octreotide acetate | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 77 77, 227 💬
|
| 121 | Octreotide acetate 30 MG suspension | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 122 | Octreotide acetate and cabergoline/octrotide and somavert | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 123 | Octreotide acetate microspheres FOR injection injection | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 124 | Octreotide acetate prolonged release, 30 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 125 | Octreotide acetato | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 77 77, 227 💬
|
| 126 | Octreotide capsules | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 127 | Octreotide fluidcrystal® injection depot | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 128 | Octreotide hydrochloride | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 129 | Octreotide implant | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 130 | Octreotide LAR | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 67 67, 77, 227 💬
|
| 131 | Octreotide LAR 30 MG injection | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 132 | Octreotide LAR 30MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 133 | Octreotide-LAR | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 67 67, 77 💬
|
| 134 | Octreotide-LAR or lanreotide | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 135 | Ogtt | - | - | - | - | [2] 77 77, 299 💬
|
| 136 | ONO-5788 | - | - | - | - | [1] 77 77 💬
|
| 137 | Oral glucose tolerance test | - | - | - | - | [6] 6 6, 13, 77, 160, 195, 299 💬
|
| 138 | Oral glucose tolerance testing | - | - | - | - | [1] 77 77 💬
|
| 139 | Paltusotine | [1] Paltusotine Paltusotine | [1] Paltusotine
Paltusotine
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 140 | Paltusotine (free base) | [1] Paltusotine Paltusotine | [1] Paltusotine
Paltusotine
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 141 | Pasireotida | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 142 | Pasireotide | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 74 74, 75, 77 💬
|
| 143 | Pasireotide 20MG | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 144 | Pasireotide 40MG | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 145 | Pasireotide 60MG | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 146 | Pasireotide diaspartate | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 147 | Pasireotide LAR | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 67 67, 75, 77 💬
|
| 148 | Pasireotide LAR 60 MG | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 149 | Pasireotide long acting release formulation | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 150 | Pasireotide pamoate | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 151 | Pegvisomant | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [2] 77 77, 265 💬
|
| 152 | Pegvisomant treatment | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 153 | Pegvisomant/ sandostatin LAR | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 154 | PHE | - | - | - | - | [2] 75 75, 77 💬
|
| 155 | PN-800467 | - | - | - | - | [1] 77 77 💬
|
| 156 | PRE-treatment with octreotide | - | - | - | - | [1] 77 77 💬
|
| 157 | Preoperative lanreotide treatment | - | - | - | - | [1] 77 77 💬
|
| 158 | Radiotherapy | - | - | - | - | [1] 77 77 💬
|
| 159 | Raloxifene | [1] Raloxifene Raloxifene | [2] Raloxifene hydrochloride
Raloxifene hydrochloride
,
Raloxifene
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 77 77 💬
|
| 160 | Recombinant human growth hormone | [1] Somatotropin Somatotropin | [1] Somatropin
Somatropin
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [4] 77 77, 193, 265, 276 💬
|
| 161 | Rosiglitazone | [1] Rosiglitazone Rosiglitazone | [2] Rosiglitazone maleate
Rosiglitazone maleate
,
Rosiglitazone
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [3] 77 77, 97, 222 💬
|
| 162 | Saline | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [19] 2 2, 6, 13, 17, 18, 46, 53, 67, 77, 86, 96, 97, 98, 168, 256, 271, 274, 299, 301 💬
|
| 163 | Sandostatin | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 164 | Sandostatin LAR | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [4] 67 67, 77, 84, 193 💬
|
| 165 | Sandostatin LAR 10 MG polvo para suspensióN inyectable | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 166 | Sandostatin LAR 10MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 167 | Sandostatin LAR 20 MG polvo para suspensióN inyectable | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 168 | Sandostatin LAR 20MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 169 | Sandostatin LAR 20MG, 30MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 170 | Sandostatin LAR 30 MG polvo para suspensióN inyectable | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 171 | Sandostatin LAR 30MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 172 | Sandostatin LAR depot | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 173 | Sandostatin LAR depot versus transsphenoidal surgery | - | - | - | - | [1] 77 77 💬
|
| 174 | Sandostatin LAR injection, 10MG, 20MG, 30MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 175 | Sandostatin LAR monatsdepot 20 MG | - | - | - | - | [1] 77 77 💬
|
| 176 | Sandostatin LAR ® (octreotide acetate LAR) 30 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 177 | Sandostatin LAR, 10 MG, 20 MG and 30 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 178 | Sandostatin LAR-monatsdepot | - | - | - | - | [1] 77 77 💬
|
| 179 | Sandostatin LAR-monatsdepot 10 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 180 | Sandostatin LAR-monatsdepot 20 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 181 | Sandostatin LAR-monatsdepot 30 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 182 | Sandostatin ® injection | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 183 | Sandostatina - LAR 20 MG/2.5 ML polvere E solvente PER sospensione iniettabile flacone polvere + siringa preriempita 2.5 ML + 2 aghi | - | - | - | - | [2] 67 67, 77 💬
|
| 184 | Sandostatina - LAR 30 MG/2.5 ML polvere E solvente PER sospensione iniettabile flacone polvere + siringa preriempita 2.5 ML + 2 aghi | - | - | - | - | [1] 77 77 💬
|
| 185 | Sandostatina LAR | - | - | - | - | [2] 67 67, 77 💬
|
| 186 | Sandostatina LAR IM FL 20MG 2F | - | - | - | - | [1] 77 77 💬
|
| 187 | Sandostatine L.P. 30 MG, poudre ET solvant EN seringue | - | - | - | - | [1] 77 77 💬
|
| 188 | Sandostatine L.P. 30 MG, poudre ET solvant pour suspension injectable à LIBération prolongéE | - | - | - | - | [1] 77 77 💬
|
| 189 | Sandostatine LAR 20 MG | - | - | - | - | [1] 77 77 💬
|
| 190 | Sandostatine long acting repeatable 30 MG | - | - | - | - | [1] 77 77 💬
|
| 191 | Sandostatin® LAR | - | - | - | - | [1] 77 77 💬
|
| 192 | Sandostatin® LAR®-monatsdepot 10 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 193 | Sandostatin® LAR®-monatsdepot 20 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 194 | Sandostatin® LAR®-monatsdepot 30 MG | [1] Octreotide Octreotide | [4] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 195 | Sign and symptoms: questionnaire | - | - | - | - | [1] 77 77 💬
|
| 196 | Signifor | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 197 | Sitagliptin | [1] Sitagliptin Sitagliptin | [3] Sitagliptin phosphate
Sitagliptin phosphate
,
Sitagliptin
,
Sitagliptin phosphate
💬
| [1] DPP4 DPP4 💬
| [2] Protein digestion and absorption Protein digestion and absorption, Virion - Hepatitis viruses 💬 | [4] 6 6, 75, 77, 299 💬
|
| 198 | SMS995 | - | - | - | - | [1] 77 77 💬
|
| 199 | SMS995B | - | - | - | - | [1] 77 77 💬
|
| 200 | SOM022 | - | - | - | - | [1] 77 77 💬
|
| 201 | SOM230 | - | - | - | - | [3] 74 74, 75, 77 💬
|
| 202 | SOM230 LAR | - | - | - | - | [2] 75 75, 77 💬
|
| 203 | SOM230 LAR, 20 MG | - | - | - | - | [2] 75 75, 77 💬
|
| 204 | SOM230, 300micrograms | - | - | - | - | [2] 75 75, 77 💬
|
| 205 | SOM230, 600 micrograms | - | - | - | - | [2] 75 75, 77 💬
|
| 206 | SOM230, 900 micrograms | - | - | - | - | [2] 75 75, 77 💬
|
| 207 | SOM230B | - | - | - | - | [2] 75 75, 77 💬
|
| 208 | SOM230C | - | - | - | - | [2] 75 75, 77 💬
|
| 209 | Somatostatin | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 210 | Somatulina autogel | - | - | - | - | [1] 77 77 💬
|
| 211 | Somatuline ATG | - | - | - | - | [1] 77 77 💬
|
| 212 | Somatuline autogel | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 67 67, 77 💬
|
| 213 | Somatuline autogel 120 | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 214 | Somatuline autogel 120 MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 215 | Somatuline autogel 120MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 216 | Somatuline autogel 60MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 217 | Somatuline autogel 90MG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 218 | Somatuline autogel injectable 120 | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 219 | Somatuline autogel® 60, 90 or 120 MG | - | - | - | - | [1] 77 77 💬
|
| 220 | Somatuline L.P. 120 MG, solution injectable à LIBération prolongéE EN seringue PRéremplie | - | - | - | - | [1] 77 77 💬
|
| 221 | Somatuline LP 120MG | - | - | - | - | [1] 77 77 💬
|
| 222 | Somatuline® autogel® 120 MG solution FOR injection | - | - | - | - | [1] 77 77 💬
|
| 223 | Somavert | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 224 | Somavert 10 MG | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 225 | Somavert 15 MG | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 226 | Somavert 20 MG | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 227 | Subcutaneous administration OF recombinant human IGF-1 | - | - | - | - | [1] 77 77 💬
|
| 228 | Surgery FOR acromegaly | - | - | - | - | [1] 77 77 💬
|
| 229 | SYHX2008 injection | - | - | - | - | [1] 77 77 💬
|
| 230 | Tadalafil | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬
| [1] PDE5 PDE5 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [7] 6 6, 51, 75, 77, 84, 86, 113 💬
|
| 231 | TE-8214 - SAD | - | - | - | - | [1] 77 77 💬
|
| 232 | Thyroid sonography | - | - | - | - | [1] 77 77 💬
|
| 233 | Total body magnetic resonance imaging | - | - | - | - | [1] 77 77 💬
|
| 234 | Transcranial magnetic stimulation | - | - | - | - | [3] 6 6, 13, 77 💬
|
| 235 | Transnasal butterfly surgery | - | - | - | - | [1] 77 77 💬
|
| 236 | Transsphenoidal adenomectomy | - | - | - | - | [1] 77 77 💬
|
| 237 | Transsphenoidal surgery | - | - | - | - | [1] 77 77 💬
|
| 238 | TRP | - | - | - | - | [3] 46 46, 75, 77 💬
|
| 239 | TYR | - | - | - | - | [3] 75 75, 77, 298 💬
|
| 240 | UNK | - | - | - | - | [1] 77 77 💬
|
| 241 | Zoledronic acid | [1] Zoledronic acid Zoledronic acid | [5] Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [13] 6 6, 13, 46, 75, 77, 93, 95, 96, 97, 270, 274, 299, 333 💬
|